ECG
BLUE

EPIQ Capital Group’s bluebird bio BLUE Stock Holding History

EPIQ Capital Group’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,181
Closed -$540K – 59
2021
Q3 		$540K Hold
2,181
– – 0.06% 41
2021
Q2 		$903K Hold
2,181
– – 0.09% 27
2021
Q1 		$852K Hold
2,181
– – 0.1% 26
2020
Q4 		$1.22M Sell
2,181
-1,990
-48% -$1.26M 0.19% 25
2020
Q3 		$2.92M Hold
4,171
– – 0.42% 15
2020
Q2 		$3.3M Buy
4,171
+482
+13% +$363K 0.56% 14
2020
Q1 		$2.2M Buy
3,689
+1,618
+78% +$1.58M 0.65% 12
2019
Q4 		$2.35M Buy
+2,071
New +$2.25M 0.58% 13

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

EPIQ Capital Group's BLUE Position: Q4 2021 in Review

EPIQ Capital Group sold out of bluebird bio (BLUE) in Q4 2021, closing a stake of 2,181 shares — an estimated $540K sold.

EPIQ Capital Group first reported a position in BLUE in Q4 2019 and held it in 8 quarters. The position peaked at $3.3M in Q2 2020. 172 funds tracked by Wall St. Rank hold BLUE as of Q4 2021.

  • EPIQ Capital Group reported no remaining bluebird bio position as of Q4 2021 after selling out during the quarter.
  • EPIQ Capital Group sold 2,181 bluebird bio shares in Q4 2021, an estimated $540K.
  • EPIQ Capital Group first reported a position in bluebird bio in Q4 2019 and held it in 8 quarters.
  • EPIQ Capital Group's bluebird bio position peaked at $3.3M in Q2 2020.
  • 172 funds tracked by Wall St. Rank held bluebird bio as of Q4 2021.

Based on EPIQ Capital Group's 13F filing for Q4 2021, filed 9 Feb 2022.